Press Releases May 7, 2026 05:00 PM

Lantronix CEO and CFO to Participate in Needham and Craig-Hallum Conferences

Lantronix CEO and CFO to present at Needham and Craig-Hallum investor conferences

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
LTRX

Lantronix Inc., a Nasdaq-listed provider of Edge AI and Industrial IoT solutions, announced that its CEO and CFO will participate in the upcoming 21st Annual Needham Technology, Media & Consumer Conference and the 23rd Annual Craig-Hallum Institutional Investor Conference. The participation includes one-on-one meetings and a fireside chat to discuss the company's strategic vision and growth opportunities in high-growth markets such as smart cities, enterprise IT, and unmanned systems.

Lantronix CEO and CFO to Participate in Needham and Craig-Hallum Conferences
LTRX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Lantronix executives to engage with investors at two major upcoming conferences in May 2026.
  • Company focuses on Edge AI and Industrial IoT solutions across multiple high-growth sectors including smart cities and defense unmanned systems.
  • Participation aims to enhance investor relations and communicate company strategy and market opportunities.

IRVINE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned systems, critical infrastructure and resilient enterprise networks, today announced that its CEO Saleel Awsare and CFO Brent Stringham will participate in the following upcoming investor conferences:

  • 21st Annual Needham Technology, Media & Consumer 1x1 Conference
    • Wednesday, May 13, Westin Grand Central Hotel, New York City
    • One-on-one meetings or fireside chat with CEO Saleel Awsare

  • Craig-Hallum 23rd Annual Institutional Investor Conference

    • Thursday, May 28, Depot Renaissance Hotel, Minneapolis
    • One-on-one meetings with CEO Saleel Awsare and Brent Stringham, CFO

About Lantronix 

Lantronix Inc. (Nasdaq: LTRX) is a global leader in Edge AI and Industrial IoT solutions, delivering intelligent computing, secure connectivity and remote management for mission-critical applications. Serving high-growth markets, including smart cities, enterprise IT and commercial and defense unmanned systems, including drones, Lantronix enables customers to optimize operations and accelerate digital transformation. Its comprehensive portfolio of hardware, software and services powers applications from secure video surveillance and intelligent utility infrastructure to resilient out-of-band network management. By bringing intelligence to the network edge, Lantronix helps organizations achieve efficiency, security and a competitive edge in today’s AI-driven world. For more information, visit the Lantronix website.

©2026 Lantronix, Inc. All rights reserved. Lantronix is a registered trademark. Other trademarks and trade names are those of their respective owners.

Lantronix Media Contact:         

[email protected] 
949-212-0960 

Lantronix Analyst and Investor Contact:         
[email protected]


Risks

  • Market reception to the presentations and insights provided by management is uncertain and could affect investor sentiment.
  • The competitive landscape in Edge AI and Industrial IoT sectors involves rapid technological changes that could impact Lantronix's growth forecasts.
  • Economic or geopolitical factors affecting defense and infrastructure sectors may influence demand for Lantronix’s solutions.

More from Press Releases

Edible Garden Receives Preliminary Approval to Sell Tax Credits Through New Jersey Economic Development Authority (NJEDA) Program Oct 9, 2026 High Roller Technologies to Present at the 2026 ThinkEquity Conference Oct 9, 2026 SkinHealth Systems Announces Reverse Stock Split Oct 9, 2026 Gentherm Announces Date for 2026 Third Quarter News Release and Conference Call Oct 9, 2026 HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors Oct 9, 2026